| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $9.07M | $7.98M | $8.66M | $10.86M | $3.09M |
| R&D | $4.06M | $3.55M | $4.15M | $5.38M | $6.91M |
| SG&A | $5.01M | $4.43M | $4.51M | $5.49M | $3.09M |
| Operating Income | -$9.07M | -$7.98M | -$8.66M | -$10.86M | -$11.95M |
| Interest Expense | – | – | – | – | $41.76K |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$8.91M | -$15.04M | -$120.25K | -$10.83M | -$2.13M |
| EPS (basic) | -23.9500 | -87.6800 | -0.5300 | -20.0900 | -1.1700 |
| EPS (diluted) | -23.9500 | -87.6800 | -0.5300 | -20.0900 | -42.5000 |
| Shares (diluted) | $620.78K | $171.51K | $228.64K | $539.04K | $282.04K |